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Whooping cough is a reemerging disease caused by two closely related pathogens, Bordetella pertussis and Bordetella paraper-
tussis. The incidence of B. parapertussis in whooping cough cases has been increasing since the introduction of acellular pertus-
sis vaccines containing purified antigens that are common to both strains. Recently published results demonstrated that these
vaccines do not protect against B. parapertussis due to the presence of the O antigen on the bacterial surface that impairs anti-
body access to shared antigens. We have investigated the effect of the lack of opsonization of B. parapertussis on the outcome of
its interaction with human neutrophils (polymorphonuclear leukocytes [PMNs]). In the absence of opsonic antibodies, PMN
interaction with B. parapertussis resulted in nonbactericidal trafficking upon phagocytosis. A high percentage of nonopsonized
B. parapertussis was found in nonacidic lysosome marker (lysosome-associated membrane protein [LAMP])-negative phago-
somes with access to the host cell-recycling pathway of external nutrients, allowing bacterial survival as determined by intracel-
lular CFU counts. The lipopolysaccharide (LPS) O antigen was found to be involved in directing B. parapertussis to PMN lipid
rafts, eventually determining the nonbactericidal fate inside the PMN. IgG opsonization of B. parapertussis drastically changed
this interaction by not only inducing efficient PMN phagocytosis but also promoting PMN bacterial killing. These data provide
new insights into the immune mechanisms of hosts against B. parapertussis and document the crucial importance of opsonic
antibodies in immunity to this pathogen.
Whooping cough is a reemerging disease caused by two closelyrelated pathogens, Bordetella pertussis and Bordetella para-
pertussis (11, 22). The exact contribution of each strain to the
epidemiological situation is not yet certain, but recent studies
have suggested that the incidence of B. parapertussis in whooping
cough cases is high and increasing (7, 16). Whooping cough vac-
cines are still derived solely from B. pertussis. These vaccines were
found to be less protective against B. parapertussis (8, 10, 40),
eventually leading to a selective advantage of B. parapertussis over
B. pertussis (3, 13, 17, 18). Accordingly, B. parapertussis has been
found to cause larger proportions of whooping cough cases than
before among vaccinated groups, with a significant increase in
prevalence after the introduction of the acellular vaccines (4, 17,
19, 35). Although closely related (24), these two strains differ in
the structure of their respective lipopolysaccharides (LPS) (2, 26).
B. pertussis exhibits a lipooligosaccharide containing lipid A and a
core oligosaccharide with a trisaccharide modification. However,
due to a deletion of the wbm locus, B. pertussis LPS lacks the O
antigen (26). B. parapertussis LPS is similar to B. pertussis LPS but
lacks the trisaccharide modification and includes an O antigen
(26, 27). According to previous studies, the O antigen is involved
in the lack of protection of pertussis vaccines against B. paraper-
tussis. In addition to conferring serum resistance (9), the O anti-
gen interferes with the binding of antibodies induced by the cross-
reactive antigens included in pertussis vaccines, preventing
bacterial opsonization (39, 40). This shielding property seems
particularly effective against antibodies induced by acellular B.
pertussis vaccines. In agreement with in vitro findings, in vivo as-
says have shown antibodies induced by B. parapertussis but not by
B. pertussis to be critical in preventing B. parapertussis coloniza-
tion (40). Both B. parapertussis-induced antibodies and neutro-
phils were found necessary for immune elimination of this bacte-
rium. Neither neutrophils nor antibodies by themselves seem to
play a major role in the dynamics of the infection of naive mice by
B. parapertussis. In the absence of either specific antibodies or
polymorphonuclear leukocytes (PMNs), B. parapertussis is able to
successfully colonize mice (38). Taken together, these findings
suggest that bacterial clearance critically depends on cellular bac-
tericidal activity mediated by opsonic antibodies and affected by
PMNs. Despite its potential importance in the epidemiology of
whooping cough, given the lack of efficient bacterial recognition
of antibodies induced by pertussis vaccines, the innate interaction
of phagocytes and B. parapertussis has not been fully investigated.
Microbial pathogens, such as B. pertussis, can survive the encoun-
ter with PMNs by interfering with their attachment, phagocytosis,
and trafficking to lysosomal compartments (14, 23, 30). In this
study, we examined the outcome of the innate interaction of B.
parapertussis with human PMNs, the role of the O antigen in this
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interaction, and the relevance of the Fc receptor (FcR) in the in-
duction of Ig-triggered cellular effector functions against B.
parapertussis.
MATERIALS AND METHODS
Bacterial strains and growth.B. parapertussis strainCN2591, the isogenic
B. parapertussis mutant strain lacking the O antigen, and strain
CN2591Dwbm, previously described (1, 26), were used in this study. For
phagocytosis experiments, these strains were transformed with plasmid
pCW505 (kindly supplied by Alison Weiss, Cincinnati, OH), which in-
duces cytoplasmic expression of green fluorescent protein (GFP) without
affecting growth or antigen expression (36). Bacteria were stored at
270°C and recovered by growth on Bordet-Gengou agar (BGA) plates
supplemented with 15% defibrinated sheep blood (bBGA) at 36°C. Viru-
lent bacteria were subsequently plated on bBGA, cultured for 20 h at 36°C,
and used in all experiments.
Antibodies. We used polyclonal rabbit antibody against human
flotillin-1 (Santa Cruz Biotechnology, Santa Cruz, CA), monoclonal
antibody (MAb) against human lysosome-associated membrane pro-
tein 1 (LAMP-1) (Pharmingen, San Diego, CA), anti-hFcgRI (CD64)
MAb 22 (mIgG1) (Medarex, Annandale, NJ), Cy3-conjugated goat
F(ab=)2 fragments of anti-rabbit immunoglobulin and fluorescein iso-
thiocyanate (FITC)-conjugated goat F(ab=)2 fragments of anti-rabbit
immunoglobulin (both from Jackson ImmunoResearch, West Grove,
PA), Cy3-conjugated goat F(ab=)2 fragments of anti-mouse immuno-
globulin and phycoerythrin (PE)-conjugated goat F(ab=)2 fragments
of anti-rabbit IgG (both from Molecular Probes, Eugene, OR), and
FITC-conjugated goat F(ab=)2 fragments of anti-mouse immunoglob-
ulin (from Southern Biotechnology).
Immunoglobulin G (IgG) fractions from pooled sera of whooping
cough patients with high titers of anti-B. parapertussis antibodies, as mea-
sured by enzyme-linked immunosorbent assay (37), were isolated as de-
scribed previously (30). Polyclonal rabbit anti-B. parapertussis antiserum
was obtained as described elsewhere (12).
Cells. Peripheral blood polymorphonuclear leukocytes (PMNs) were
isolated from heparinized venous blood using Ficoll-Histopaque (Sigma,
St. Louis, MO) gradient centrifugation. PMNs were harvested, and the
remaining erythrocytes were removed by hypotonic lysis. Cell viability
was 99% as determined by trypan blue exclusion. Prior to functional
assays, PMNswere washed twice withDulbecco’smodified Eaglemedium
(DMEM) (HyClone) supplemented with 10% heat-inactivated fetal calf
serum (FCS) (HyClone), suspended, and used immediately. All experi-
mentswere carried outwith freshly isolated PMNs lacking FcgRIa (CD64)
expression, as monitored by fluorescence-activated cell sorter (FACS)
analysis using a FACScalibur flow cytometer with anti-hFcgRI MAb 22
(mIgG1) (28). Data were processed using the CellQuest software (BD
Biosciences).
Cholesterol sequestration of PMNs. Cholesterol sequestration was
achieved by incubating PMNs with 10 mg/ml of b-methyl cyclodextrin
(Sigma) (15 min at 37°C) or 35 mg/ml of nystatin (Sigma) (30 min at
37°C) in serum-free DMEM plus bovine serum albumin (BSA) (0.2%)
and lovastatin (5 mg/ml) (Sigma) (DMEM-BSA-L). Cells were then
washed, suspended inDMEM-BSA-L, andused immediately.Nodecrease
in PMN viability was detected after treatment.
Quantification of phagocytosis. Bacterial phagocytosis was evaluated
by confocal microscopy. PMNs were incubated with nonopsonized B.
parapertussis at amultiplicity of infection (MOI) of 30 or 300 (bacteria per
cell) for 15 min at 37°C to allow bacterial interaction with the PMNs. In
select experiments, 200 ng/ml cytochalasin D (Sigma) was added to in-
hibit phagocytosis (34). PMNs were extensively washed to remove non-
attached bacteria and further incubated for 1 h at 37°C. Phagocytosis was
stopped by placing the PMNs on ice. Cells were then fixed using 4%
paraformaldehyde. After fixation, the PMNswerewashed oncewith phos-
phate-buffered saline (PBS) and incubated for 10 min at room tempera-
ture with PBS containing 50 mM NH4Cl. PMN surface-bound bacteria
were detected by a two-step labeling procedure. The PMNs were incu-
bated with polyclonal rabbit anti-B. parapertussis antiserum (30 min at
4°C), followed by incubationwithCy3-conjugated goat F(ab=)2 fragments
of anti-rabbit immunoglobulin for another 30 min at 4°C. In order to
determine the number of intracellular bacteria after two washing steps,
the cells were permeabilized by incubation with PBS containing 0.1%
saponin (Sigma-Aldrich) and 0.2%BSA for 30min and further incubated
for another 30minwith rabbit anti-B. parapertussis antiserum in the pres-
ence of 0.1% saponin and 0.2%BSA. After washing three times, the PMNs
were incubated (30min) with FITC-conjugated F(ab=)2 fragments of goat
anti-rabbit IgG1. Labeling of the bacteria with FITC-conjugated antibod-
ies was performed to minimize the loss of read-out sensitivity due to the
quenching ofGFPfluorescence after internalization. Finally, the cells were
spun on microscope slides. Microscopic analyses were performed using a
confocal laser scanning microscope (model TCS SP5; Leica, Germany).
The number of extracellular (red and green fluorescent) and intracellular
(green fluorescent) bacteria per cell was determined by microscopic ex-
amination of 20 randomly selected fields showing a minimum of 5 cells
per field. In select experiments, B. parapertussis was opsonized with hu-
man IgG (200 mg/ml) prior to incubation with PMNs at an MOI of 30.
Respiratory burst determination. Reactive oxygen species (ROS)
production by PMNs was determined as described previously (32).
Briefly, tubes containing 50 ml with 3 3 106 IgG-opsonized bacteria or
33107 nonopsonized bacteria were transferred to a luminometer (Lumi-
noskan TL Plus; Thermo Lab Systems, Finland), in which the chemolu-
minescence response of 105 PMNswasmeasured everyminute for 30min
at 37°C, after the injection of 600 ml of 180 mM luminol (Sigma).
Confocal microscopy analysis. Colocalization studies were per-
formed as described previously (15) with minor modifications. Briefly,
PMNs were incubated with nonopsonized wild-type B. parapertussis
(MOI, 30 or 300), nonopsonized B. parapertussis Dwbm (MOI, 300), or
IgG-opsonized B. parapertussis (MOI, 30) for 15 min at 37°C, washed to
remove nonattached bacteria, and further incubated for another hour at
37°C. In select experiments, cell samples were taken every 20 min during
a 2-h incubation at 37°C. The infected cells were incubated with or with-
out 200 nM LysoTracker DND-99 (Molecular Probes) (5 min at 37°C),
followed by fixation with paraformaldehyde. Those samples that were not
incubated with LysoTracker stain were washed twice with PBS and incu-
bated for 10 min at room temperature with PBS containing 50 mM
NH4Cl. After two washing steps, the cells were incubated for 30 min with
PBS containing 0.1% saponin (Sigma) and 0.2% BSA, followed by incu-
bation with polyclonal rabbit anti-B. parapertussis antiserum (30 min at
4°C) in the presence of 0.1% saponin and 0.2% BSA. After three washing
steps, the PMNs were incubated with FITC-conjugated goat F(ab=)2 frag-
ments of anti-rabbit immunoglobulin for another 30min at 4°C. Samples
of infected cells incubated for 1 h at 37°C that were not incubated with
LysoTracker stain were washed twice with PBS and incubated for 10 min
at room temperaturewith PBS containing 50mMNH4Cl. After twowash-
ing steps, the cells were incubated for 30 min with PBS containing 0.1%
saponin (Sigma) and 0.5% BSA. Next, the cells were incubated for 30min
at 4°C with either mouse anti-human LAMP-1 monoclonal antibodies plus
polyclonal rabbit anti-B. parapertussis antiserumor rabbit anti-human flotil-
lin-1 plus polyclonal mouse anti-B. parapertussis antiserum antibodies (30
min at 4°C) in the presence of 0.1% saponin and 0.2% BSA. After three
washing steps, the cells were incubated with either Cy3-conjugated F(ab=)2
fragments of goat anti-mouse antibodies plus FITC-conjugated goat F(ab=)2
fragments of anti-rabbit immunoglobulin or Cy3-conjugated F(ab=)2 frag-
ments of goat anti-rabbit antibodies plus FITC-conjugated goat F(ab=)2 frag-
ments of anti-mouse immunoglobulin for another 30 min at 4°C. To avoid
cytophilic binding of antibodies to the FcgR, all incubationswere done in the
presence of 25% heat-inactivated human serum. Additionally, isotype con-
trols were run in parallel.
Microscopic analyses were performed using a confocal laser scanning
microscope (model TCS SP5; Leica, Germany). The percentage of phago-
somes containing the bacterium that colocalized with a given marker was
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calculated from the number of total intracellular bacteria by analyzing at
least 50 phagosomes per donor.
Transferrinuptake.Theuptake of transferrin byPMNswas assayed as
described previously (33), with minor modifications. Briefly, PMNs were
incubated with nonopsonized wild-type B. parapertussis (MOI, 300),
nonopsonized B. parapertussis Dwbm (MOI, 300), or IgG-opsonized B.
parapertussis (MOI, 30) for 15 min at 37°C, depleted of transferrin by
incubation in DMEM containing 1% BSA for 1 h at 37°C, and further
incubated for 10 min at 4°C with 10mg/ml Alexa transferrin-594 (Molec-
ular Probes) in an excess of BSA (1%) to saturate nonspecific endocytosis.
Next, the cells were incubated for 5min at 37°C to allow internalization of
the ligand, washed with DMEM containing 1% BSA, and further incu-
bated for another 45 min at 37°C. Finally, the cells were fixed, and micro-
scopic analyses were performed using a confocal laser scanning micro-
scope. At least 50 bacteria per donor were analyzed for colocalization with
transferrin in each experiment.
Killing assay. PMNs were incubated with nonopsonized wild-type B.
parapertussis (MOI, 300), nonopsonized B. parapertussis Dwbm (MOI,
300), or IgG-opsonized B. parapertussis (MOI, 30). Bacterial inocula were
quantified by plating appropriate dilutions on bBGA. After 15 min of
incubation at 37°C with 5% CO2, nonadherent bacteria were removed
through three washing steps. Then, 100 mg/ml polymyxin B sulfate
(Sigma) was added for 1 h to kill the extracellular bacteria (5). The PMNs
were washed, and B. parapertussis intracellular survival was determined as
follows. Infected PMNs were pelleted, and the number of viable eukary-
otic cells was determined by trypan blue dye exclusion. Next, the PMNs
were lysed with 0.1% saponin in sterile water, and serial dilutions of ly-
sates were rapidly plated onto bBGA to enumerate the CFU. Control
experiments to assess bacterial phagocytosis under each condition by con-
focal microscopy were run in parallel to be used to calculate the percent-
age of intracellular bacteria that were still alive 1 h after phagocytosis.
Additionally, control experiments to assess the efficacy of antibiotic bac-
tericidal activity were also performed in parallel. Briefly, samples of 5 3
108 bacteria were incubated with antibiotics for 1 h at 37°C and plated on
bBGA. This resulted in a 99.999% decrease in the CFU. No significant
differences in bacterial sensitivity to the antibiotics were detected among
the strains tested, either opsonized or nonopsonized. Additionally, the
number of CFU in the cell culture supernatants was examined. No viable
bacteria were detected at any time postinfection.
Statistical analysis. Student’s t test (95% confidence level) or analysis
of variance (ANOVA) was used for statistical data evaluation. The signif-
icance of the differences between themean values of the data evaluated by
ANOVA was determined with the least-significant-difference (LSD) test
at a 95% confidence level. Results are shown as means and standard devi-
ations (SD).
RESULTS
The O antigen is involved in PMN phagocytosis of nonop-
sonized B. parapertussis. The LPS O antigen is considered a vir-
ulence determinant for other Gram-negative bacteria because,
among other reasons, it shapes bacterial uptake by immune cells
(21). In this study, we evaluated the role of LPSO antigen in PMN
phagocytosis of B. parapertussis. We used two-color confocal mi-
croscopy in order to quantify the actual number of bacteria asso-
ciated with PMNs while discriminating between intracellular and
extracellular bacteria. Figure 1A shows that the O antigen of B.
parapertussis affects bacterial interaction with human PMNs.
PMN uptake of a B. parapertussismutant defective in the O anti-
gen was significantly higher than that of the wild-type strain. In
order to investigate whether the O antigen of B. parapertussis is
involved in bacterial attachment or bacterial internalization, we
evaluated the interaction of B. parapertussis and a B. parapertussis
mutant defective in O antigen with human PMNs in the presence
of cytochalasin D, an inhibitor of microfilament polymerization.
The differences shown in Fig. 1B resemble the differences shown
in Fig. 1A. These results, together with the finding that after 1 h at
37°C most of the bacteria were found inside the cell in both cases
(data not shown), suggest that the O antigen is implicated mainly
in bacterial attachment, which might indicate different PMN tar-
gets for O antigen-expressing and O antigen-lacking B. paraper-
tussis.
LPSO antigen-mediated interaction ofB. parapertussiswith
PMNs delivers the bacteria to compartments that do not fuse
with lysosomes. O antigen-mediated phagocytosis was found
previously to be associated with the delivery of bacteria through a
pathway that avoids phagosome-lysosome fusion, eventually pre-
venting cellular bactericidal activity (25). The intracellular routing
FIG 1 PMN attachment and phagocytosis of Bordetella parapertussis. (A)
PMNphagocytosis of wild-type B. parapertussis (Bpp) andO antigen-deficient
B. parapertussis (BppDwbm). The bacteria were incubated with PMNs (MOI,
300) for 15min at 37°C. After attachment, the PMNs were washed and further
incubated for 1 h at 37°C to allow internalization. The cells were fixed and
permeabilized prior to labeling the intracellular bacteriawith greenfluorescent
dye and the extracellular bacteria with both green and red fluorescent dyes.
Bacterial phagocytosis was assessed by confocal laser scan fluorescencemicros-
copy. To assess the number of phagocytosed bacteria, at least 100 cells were
counted per slide. The data represent themeans6 SDof four experimentswith
PMNs from different donors. Phagocytosis of nonopsonized B. parapertussis
by PMNs differed significantly from the PMN phagocytosis of B. parapertussis
Dwbm. The asterisk indicates a P value of ,0.05. (B) PMN attachment of B.
parapertussis. Wild-type B. parapertussis and O antigen-deficient B. paraper-
tussiswere incubated with PMNs (MOI, 300) in the presence of cytochalasin D
for 15 min at 37°C. PMNs were then washed and further incubated for 1 h at
37°C in the presence of cytochalasin D. The cells were fixed and permeabilized
prior to labeling the intracellular bacteria in green fluorescent dye and the
extracellular bacteria with both green and red fluorescent dyes. Bacterial at-
tachment was assessed by confocal laser scan fluorescence microscopy. To
assess the number of PMN-attached bacteria, at least 100 cells per slide were
counted. No bacteria exhibiting only green fluorescence were observed in any
cells after 1 h of incubation at 37°C, indicating that phagocytosis was efficiently
blocked. The data represent the means6 SD of four experiments with PMNs
from different donors. The attachment of B. parapertussis by PMNs differed
significantly from PMN attachment of B. parapertussis Dwbm. The asterisk
indicates a P value of,0.05.
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of nonopsonized B. parapertussiswas investigated by confocal mi-
croscopy. We first evaluated nonopsonized B. parapertussis colo-
calization with the acidotropic LysoTracker dye at different time
points postinfection. Figure 2 shows that 1 h after infection, most
B. parapertussis-containing vacuoles were nonacidic, as attested
by the lack of accumulation of the acidotropic dye in 63%6 4%of
the Bordetella-containing phagosomes. Importantly, this percent-
age did not change at later time points (Fig. 2).
We next investigated the relevance of the O antigen in this
transportation to nonacidic compartments. Figure 2 shows that
the percentage of O antigen-deficient B. parapertussis found in
LysoTracker-positive phagosomes was significantly higher than
that observed in the nonopsonized wild-type strain, indicating
that the O antigen is involved in the ability of B. parapertussis to
impair phagolysosome maturation.
We then evaluated whether the intracellular fate of B. paraper-
tussis could be modified by bacterial opsonization with specific
antibodies. PMNuptake ofB. parapertussis drastically increased in
the presence of opsonins (data not shown). The MOI had to be
reduced 10 times in order to achieve a level of infection compara-
ble to that obtained with nonopsonized bacteria. Figure 2B shows
that IgG-opsonized bacteria were mainly transported to acidic
organelles, indicating that the ability to impair phagolysosome
maturation was abrogated by IgG opsonization of the bacteria. In
order to investigate whether the multiplicity of infection was in-
volved in the differences in intracellular trafficking, we evaluated
the fate of nonopsonized B. parapertussis incubated with PMNs at
theMOI used for opsonized bacteria (MOI, 30). Although a lower
number of bacteria were found inside human PMNs, the results
showed that most intracellular bacteria were not colocalized with
LysoTracker (data not shown).
The characteristics of theB. parapertussis-containing compart-
ments were then investigated. As can be seen in Fig. 3A and con-
sistent with the low percentage of acidic phagosomes found 1 h
postinfection (Fig. 2), nonopsonized B. parapertussis-containing
phagosomes were mainly negative for the late-endosomal and -lyso-
somal marker LAMP-1 at this time point. These results suggest that
those bacteria that successfully evaded transportation to acidic com-
partments eventually remained in the phagosomes lacking lysosomal
or late endosomal characteristics. In agreement with the higher vol-
umeofbacterial trafficking to lysosomal compartments shown inFig.
2, IgG opsonization as well as the lack of O antigen resulted in a
significant increase in bacterial colocalization with the late-endo-
somal and -lysosomal marker LAMP-1 (Fig. 3A).
Since most of the nonopsonized B. parapertussis bacteria were
found outside late-endosomal and -lysosomal compartments,
they might have access to nutrients via the recycling pathway. In
order to evaluate this issue, we pulsed the PMNs with Alexa trans-
ferrin-594 to assess the bacterial access to extracellular material.
As can be seen in Fig. 3B, 59% 6 5% of nonopsonized B. para-
pertussis-containing phagosomes were positive for transferrin 1 h
postinfection, suggesting that these bacteria are located in vacu-
oles in which they have access to recycling endosomes. Consistent
with the higher percentage of bacteria located in lysosomal com-
partments (Fig. 2), the percentage of colocalization of both
opsonized B. parapertussis and the O antigen-deficient B. para-
pertussismutant with transferrin was significantly lower than that
observed for nonopsonized B. parapertussis (Fig. 3B).
The LPS O antigen precludes PMN activation during inter-
action with nonopsonized B. parapertussis.As the differences in
intracellular bacterial trafficking might be indicating differences
in the PMN activation state, we evaluated the effect of the O anti-
gen on the respiratory burst response of PMNs. As shown in Fig. 4,
nonopsonized O antigen-deficient B. parapertussis induced a sig-
nificant respiratory burst response in human PMNs, but no activ-
ity was detected with the nonopsonized wild-type strain, suggest-
ing that the O antigen prevents PMN activation. As expected,
IgG-opsonized B. parapertussis induced a high respiratory burst
response in PMNs (Fig. 4).
PMN intracellular survival of B. parapertussis depends on
the O antigen. Given that the lack of opsonization seems to favor
intracellular trafficking of B. parapertussis to nonbactericidal
compartments, and no PMN activation was detected in the ab-
sence of opsonins, we next investigated the intracellular survival of
B. parapertussis upon interaction with PMNs in both the presence
and the absence of opsonic antibodies. Nonopsonized B. paraper-
tussis survival upon phagocytosis was significantly higher than op-
sonized bacterial survival (Fig. 5). Moreover, in agreement with
the confocal microscopy studies and the induction of PMN ROS
production described above, the lack of expression of the O anti-
gen led to a significant reduction of intracellular survival of non-
opsonized B. parapertussis, confirming that the O antigen is
involved in innate PMN-bacterium interaction, eventually de-
creasing cellular bacterial killing.
Lipid raft domains are involved in O antigen-dependent B.
parapertussis survival to PMN phagocytosis. LPS O antigen was
found previously to be involved in directing the pathogen through
an endocytic pathway that avoids fusionwith lysosomes by target-
ing the host cell lipid rafts (25). Since our results suggested an
essential role of the O side chain in avoiding the lysosomal path-
way and bacterial killing, we next investigated the role of choles-
terol-rich domains in the innate interaction of PMNs and nonop-
sonized B. parapertussis. Treatment of PMNs with b-methyl
cyclodextrin, a compound that disrupts cholesterol-rich domains
by extracting cholesterol (29), led to a significant decrease in the
level of phagocytosis of nonopsonized B. parapertussis.
The experiments were performed in the presence of lovastatin
to inhibit de novo cholesterol synthesis. Similar results were ob-
tained with PMNs incubated with nystatin, a cholesterol-binding
drug (Fig. 6). Conversely, phagocytosis of O antigen-defective B.
parapertussis to PMNs did not change significantly after the incu-
bation of PMNs with either nystatin or b-methyl cyclodextrin
(Fig. 6), indicating that the O antigen is involved in directing B.
parapertussis to cholesterol-rich domains.
We further investigated this association by confocal micros-
copy using a lipid raft marker, flotillin. Around 80% of the wild
type but not the O antigen-defective B. parapertussismutant bac-
teria were found colocalizing with flotillin-enriched areas (Fig. 7),
confirming the involvement of lipid rafts in the interaction of B.
parapertussis with PMNs.
Next, we examined whether the entry of B. parapertussis
through the lipid rafts is required for bacterial survival of PMN
phagocytosis. Treatment of PMNswithb-methyl cyclodextrin led
to a significant reduction of intracellular survival of nonopsonized
wild-type B. parapertussis, whereas the survival of the O antigen-
defective mutant of B. parapertussis was unaffected, indicating
that the uptake of B. parapertussis through cholesterol-rich do-
mains decreases cellular bacterial killing. Similar results were ob-
tained with PMNs incubated with nystatin (Fig. 8).
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FIG 2 PMN intracellular trafficking of B. parapertussis. Nonopsonized B. parapertussis (Bpp), nonopsonized B. parapertussis Dwbm, or IgG-opsonized B.
parapertussis were incubated with human PMNs (MOI, 300 for nonopsonized bacteria and 30 for IgG-opsonized bacteria) for 15 min at 37°C. After washing,
samples were taken at different time points, and bacterially infected PMNs were incubated with LysoTracker and fixed prior to being subjected to confocal
microscopic analysis. (A) Time course of the respective percentages of LysoTracker-positive bacteria. The data represent the means6 SD of three independent
experiments. (B) PMNs with green fluorescent bacteria 1 h after infection. Colocalization is reflected by the yellow areas. Representative confocal microscopy
images of one of three independent experiments are shown.
FIG 3 Confocal laser scanning fluorescencemicroscopic analyses of B. parapertussis colocalization with LAMP-1 and transferrin. Nonopsonized B. parapertussis
(Bpp), nonopsonized B. parapertussis Dwbm, or IgG-opsonized B. parapertussis was incubated with human PMNs (MOI, 300 for nonopsonized bacteria and 30
for IgG-opsonized bacteria) for 15min at 37°C. After washing, the bacterially infected PMNswere incubated for 1 hourmore at 37°C and fixed and permeabilized
prior to incubation with antibodies against LAMP-1 (A) or incubated with Alexa transferrin-594 before fixing (B). Shown are green fluorescent bacteria inside
PMNs. Colocalization is reflected by the yellow areas. The bars indicate the respective percentages of LAMP-1-positive or transferrin-positive phagosomes. The
data represent the means 6 SD of three independent experiments. Representative confocal microscopy images of one of three independent experiments are
shown. The asterisks indicate significance (P, 0.05).
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B. parapertussis is a successful pathogen that has persisted within
vaccinated populations for decades. A substantial mass of evi-
dence shows that the contribution of B. parapertussis infection to
whooping cough has been increasing over the last years (7, 17, 35).
Recent surveys have shown that the growing incidence of this
pathogen roughly coincides with the introduction of the acellular
vaccine. Whooping cough vaccines have little, if any, efficacy
against this bacterium (8, 10, 17, 40). Acellular vaccines were
found particularly ineffective. Recent studies have shown that the
O antigen is responsible for the lack of cross protection between
these two strains. O antigen shields B. parapertussis from B. per-
tussis vaccine-induced antibodies, preventing antibody-mediated
phagocytosis in vitro and antibody-mediated clearance in vivo
(40). The ability of professional phagocytes to ingest and kill mi-
croorganisms is central to innate immunity and host defense.
Many persistent pathogens,B. pertussis among them, have evolved
strategies to avoid killing by immune cells (14, 23, 31). Since cur-
rent pertussis vaccines fail to induce opsonic activity against B.
parapertussis, the outcome of the innate interaction of this patho-
gen with human PMNsmight be of particular relevance in under-
standing whooping cough epidemiology. The data shown here
demonstrate that in the absence of opsonic antibodies, PMN up-
take of B. parapertussis does not result in effective cellular bacte-
ricidal activity. Unlike bacterial phagocytosis via the FcR, in the
absence of antibodies B. parapertussis seems able to disrupt nor-
mal endosomal maturation and fusion with lysosomes. A high
percentage of nonopsonized bacteria exhibits nonbactericidal
trafficking inside the PMNs once phagocytosed. Our data indicate
that B. parapertussis is able to inhibit its own trafficking to lyso-
somes and remain viable inside the immune cell. The LPS O anti-
gen was found to be involved in this immune evasionmechanism.
Our results showed that the O antigen not only reduces B. para-
pertussis uptake by PMNs but is also involved in precluding
phagolysosomematuration. A B. parapertussismutant strain lack-
ing the expression of theOantigen showed a significant increase in
PMN uptake and in the percentage of colocalization with lyso-
somalmarkers 1 h after phagocytosis. Accordingly, the O antigen-
deficient mutant, unlike the wild-type strain of B. parapertussis,
activated the PMNs andwasmore efficiently killed by the immune
cell. The O antigen of other bacterial pathogens has been found to
be involved in phagolysosome fusion inhibition by targeting host
cell lipid rafts. Bacterial raft association usually generates a phago-
some enriched in raft components which eventually preclude
phagolysosome fusion (20). Our results suggest that a similar
mechanism might underlie the O antigen dependency of B. para-
pertussis survival to the native interaction with the PMNs. Uptake
of the wild-type but not the O antigen-deficient mutant of B.
parapertussis was found to be dependent on intact lipid rafts. O
antigen dependency of bacterial association with these cholesterol-
FIG 4 Bacterial induction of PMN respiratory burst. Nonopsonized B. parap-
ertussis (Bpp), nonopsonized B. parapertussis Dwbm, or IgG-opsonized B.
parapertussis was incubated with PMNs (MOI, 30 for opsonized bacteria and
300 for nonopsonized bacteria) and luminol at 37°C. PMNs incubated with
buffer and luminol served as a control. Chemiluminescence responses were
measured every minute for 20 min. Data are representative of four indepen-
dent experiments. RLU, relative luminometric units.
FIG 5 B. parapertussis survival in human PMNs. Nonopsonized B. para-
pertussis (Bpp), nonopsonized B. parapertussis Dwbm, or IgG-opsonized B.
parapertussis was incubated with human PMNs (MOI, 300 for nonopsonized
bacteria and 30 for IgG-opsonized bacteria) for 15 min at 37°C, washed, and
further incubatedwith polymyxin B to kill the extracellular bacteria. The num-
ber of CFU of B. parapertussis per cell was determined. Bacterial killing was
expressed as the percentage of intracellular bacteria that were still alive 1 h after
phagocytosis. The data represent themeans6 SD of three independent exper-
iments. The number of viable intracellular nonopsonized B. parapertussis per
cell was significantly different from the number of viable intracellular op-
sonized B. parapertussis and O antigen-deficient B. parapertussis (the asterisk
indicates a P value of,0.05).
FIG 6 Effect of b-methyl cyclodextrin and nystatin on PMN phagocytosis of
B. parapertussis. Nonopsonized B. parapertussis (Bpp) and nonopsonized B.
parapertussis Dwbm were treated with or without cholesterol-depleting (b-
methyl cyclodextrin, 10 mg/ml) or cholesterol-binding (nystatin, 35 mg/ml)
drugs prior to incubation with nonopsonized B. parapertussis or nonop-
sonized B. parapertussisDwbm (both atMOIs of 300) for 15min at 37°C. After
attachment, the PMNs were washed and further incubated for 1 h at 37°C to
allow internalization. The cells were fixed and permeabilized prior to labeling
the intracellular bacteria with green fluorescent dye and the extracellular bac-
teria with both green and red fluorescent dyes. To assess the number of phago-
cytosed bacteria, at least 100 cells per slide were counted. For each strain, the
control (100% value) was obtained with untreated PMNs. The data represent
the means 6 SD of four experiments with PMNs from different donors.
Phagocytosis of nonopsonized B. parapertussis by b-methyl cyclodextrin or
nystatin-treated PMNs was significantly different from phagocytosis by un-
treated PMNs (P, 0.05).
Gorgojo et al.
4314 iai.asm.org Infection and Immunity







rich domains was confirmed by confocal microscopy using a lipid
raft marker, flotillin. B. parapertussis wild type but not the O an-
tigen-deficient mutant was found colocalizing with flotillin-en-
riched areas. Importantly, B. parapertussis survival was found to
be dependent on the presence of both the O antigen and the intact
lipid rafts. The lack of O antigen, or PMN treatment with raft-
disrupting drugs, significantly increased B. parapertussis killing by
the immune cell. Our results suggest a key role of the PMN lipid
raft in the entry and survival of B. parapertussis under nonopsonic
conditions and a central role of the O side chain of the LPS in
directing the bacteria to these lipid platforms. Taken together,
these data identify the O antigen expression as an innate immune
evasion mechanism during B. parapertussis infection. These re-
sults might explain the dependence on O antigen for B. paraper-
tussis respiratory tract colonization (6). Interestingly, although
bothB. parapertussis andB. pertussis (14) strains are able to survive
the interaction with this aggressive immune cell, only B. paraper-
tussis seems to critically depend on theO antigen. B. pertussis lacks
this LPS side chain, which may reflect O antigen-independent
host-bacterium interactions that are unique to B. pertussis.
B. parapertussis uptake by PMNs, ROS production, and bacte-
ricidal activity drastically increase in the presence of opsonic an-
tibodies. Bacterial phagocytosis mediated by FcR led to a signifi-
cant enhancement in the proportion of bacteria colocalizing with
lysosomal markers 1 h after phagocytosis, eventually leading to
efficient bacterial killing. In fact, the presence of antibodies in-
creases the overall bacterial killing 200 times. These results are in
agreement with previous in vivo data showing the critical role of
both antibodies and PMNs, but not PMNs alone (38), for B.
parapertussis clearance and underline the critical importance of
the presence of opsonic antibodies at the site of infection.
In summary, according to previous data and the data presented
here, the O antigen protects B. parapertussis not only from B.
pertussis vaccine or B. pertussis infection-induced antibodies (39,
40) but also from being killed by innate interaction with PMNs in
nonimmune hosts. These results reinforce prior calls to consider
inclusion of the O antigen in whooping cough vaccines.
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